Melane Sampson, Author at BioTuesdays

Developments

Trinity Biotech unveils new microsite to highlight distinctive technology and AI-driven platform

Trinity Biotech (NASDAQ: TRIB) has announced the launch of its continuous glucose monitoring (CGM) microsite to provide insights into the development of its next-generation CGM biosensor technology and AI-driven health...

June 3, 2024

Developments

Verve Therapeutics appoints Troy Lister as CSO

Verve Therapeutics (NASDAQ:VERVE) has appointed Troy Lister, Ph.D., as CSO, effective June 21, 2024, succeeding Andrew Bellinger, M.D., Ph.D., who will serve in an advisory capacity. Currently, Dr. Lister serves as...

June 3, 2024

Developments

Lucy Therapeutics secures new funding to accelerate innovative Alzheimer’s and Parkinson’s Treatments

Closely-held Lucy Therapeutics (LucyTX) raised $12.5 million in additional funding to further the company’s research programs for Alzheimer’s and Parkinson’s diseases and continue its development of a novel drug target...

May 29, 2024

Developments

BerGenBio announces NCI clinical collaboration with UT Health San Antonio and Swedish Orphan Biovitrum AV

BerGenBio ASA (OSE: BGBIO) has announced that it has entered into a clinical trial agreement with the Mays Cancer Center at UT Health San Antonio and Swedish Orphan Biovitrum AV to study BerGenBio’s selective AXL...

May 29, 2024

Developments

Elixir Medical reports positive data from stress system to treat calcified lesions trial

Closely-held Elixir Medical has announced positive results from its PINNACLE I clinical trial evaluating the safety and effectiveness of its novel LithiX Hertz Contact Lithotripsy (IVL) System that uses stress to treat...

May 17, 2024

Developments

Takeda’s dengue vaccine receives WHO prequalification

Takeda (TSE: 4502/NYSE: TAK) TAK-003, a new dengue vaccine, has obtained WHO prequalification. WHO has also recommended TAK-003 for children aged six to 16 in regions that are at risk of the mosquito-borne viral disease...

May 16, 2024

Developments

Profound Medical receives FDA 510(k) clearance for ‘Contouring Assistant’ AI module enabling creation of automated TULSA treatment plan

Profound Medical (NASDAQ:PROF; TSX:PRN) announced that it has received FDA 510(k) clearance for its second TULSA-AI module, Contouring Assistant, a machine learning-based prostate segmentation tool, for use in...

May 14, 2024

Feature

Vizgen championing the power of spatial genomics with unprecedented transformative insight into biological systems

Closely held Vizgen is pioneering next-generation genomics and benchmarking the spatial genomics field with its commercial MERSCOPE Platform, the industry’s first high plex in situ single-cell spatial genomics solution...

May 7, 2024

Feature

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Closely-held xNARA Biologics is reshaping the wellness industry through personalized health and wellness solutions designed to address genetic predispositions and disorders identified by analyzing individual DNA, gut...

January 9, 2024

Feature

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Closely held Simtra BioPharma Solutions, a premier contract development and manufacturing organization with more than 65 years of sterile injectable manufacturing experience, offers world-class cGMP sterile fill/finish...

December 19, 2023

Author - Melane Sampson

Trinity Biotech unveils new microsite to highlight distinctive technology and AI-driven platform

Verve Therapeutics appoints Troy Lister as CSO

Lucy Therapeutics secures new funding to accelerate innovative Alzheimer’s and Parkinson’s Treatments

BerGenBio announces NCI clinical collaboration with UT Health San Antonio and Swedish Orphan Biovitrum AV

Elixir Medical reports positive data from stress system to treat calcified lesions trial

Takeda’s dengue vaccine receives WHO prequalification

Profound Medical receives FDA 510(k) clearance for ‘Contouring Assistant’ AI module enabling creation of automated TULSA treatment plan

Vizgen championing the power of spatial genomics with unprecedented transformative insight into biological systems

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Subscribe